Poseida Therapeutics (STU:2RZ) Accumulated Depreciation : €-20.01 Mil (As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Poseida Therapeutics Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Poseida Therapeutics's quarterly accumulated depreciation increased from Dec. 2023 (€-17.25 Mil) to Mar. 2024 (€-18.57 Mil) and increased from Mar. 2024 (€-18.57 Mil) to Jun. 2024 (€-20.01 Mil).

Poseida Therapeutics's annual accumulated depreciation increased from Dec. 2021 (€-8.09 Mil) to Dec. 2022 (€-12.72 Mil) and increased from Dec. 2022 (€-12.72 Mil) to Dec. 2023 (€-17.25 Mil).

Poseida Therapeutics Accumulated Depreciation Historical Data

The historical data trend for Poseida Therapeutics's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poseida Therapeutics Accumulated Depreciation Chart

Poseida Therapeutics Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated Depreciation

Get a 7-Day Free Trial

-1.81

-3.78

-8.09

-12.72

-17.25

Poseida Therapeutics Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Accumulated Depreciation	Get a 7-Day Free Trial															-14.95	-16.52	-17.25	-18.57	-20.01

Poseida Therapeutics Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Poseida Therapeutics Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Poseida Therapeutics's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Poseida Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poseida Therapeutics Inc (STU:2RZ) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

PSTX:USA

Address

9390 Towne Centre Drive, Suite 200, San Diego, CA, USA, 92121

Website

https://www.poseida.com

Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.

Poseida Therapeutics Headlines

No Headlines